[ORGANIZATION]
Tovinontrine
Featured in 1 tracked story · first seen
Situations
[QUIET]
[HEALTH]
HFSA 2026 heart failure clinical trial data
2 clusters · 3 sources · last updated
Latest: Tovinontrine 50 mg improves cGMP but shows minimal NT-proBNP effect in HFpEF trial
At the Heart Failure Society of America (HFSA) 2026 annual meeting, clinical data were presented for several heart failure treatments. Cardurion Pharmaceuticals reported Phase 2 results for the PDE9 inhibitor tovinontri